Newsletter

Apple Comment; Trade For the Week; Using RSS Feeds

  February 23, 2008  
  Volume IX, Issue 15  
Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:
 

RSS Feeds: A Great Solution In A Filtered World

Emailing has become a bit fickle over the last couple of years. Spamming rather crude sales pitches for everything from Viagra to $50 million free money from Nigeria, to identity theft still jams our inboxes.

There are filters everywhere to catch offending correspondence- your own computer's email software probably has one, your company's IT guy has probably installed one for the workplace, and the ISPs have their own indecipherable filtering. 

A lot of the nasty stuff gets filtered out, but a lot of mail you want to see gets filtered out as well. I am constantly finding correspondence from associates in my SPAM filter.

If you want to receive the OTC Journal more efficiently, there are several ways to insure prompt receipt. Here's the irony- if you are reading this, you are probably getting my publication on cue. However, let's look at some of the choices anyway.

First, there's "White Listing" the OTC Journal. The ability to White List depends on the email software you use, and the filtering technology you might have as well. For instructions on White Listing the newsletter, simply click on the following link: http://www.otcjournal.com/whitelist/, and you will be taken to an instruction page.

There's is an even better alternative which has been around for a while, and is becoming more and more popular. You can get the OTC Journal editions and BLOGS by directing the content wherever you want to see it using an RSS Feed.

RSS is an acronym for Really Simple Syndication. The simplified explanation: Whenever content is published at a place you want to view it, you can instruct either your email software or your browser to reach out on to the internet, grab it, and bring it to you. No email required, and only what you want to see.

It works really well if you use a Yahoo! home page, Microsoft Outlook to receive your emails, or Internet Explorer. Yahoo! is the easiest. Simply go to the home page at www.OTCJOURNAL.com, and click on the Yahoo! RSS Feeds at the top of the RSS box- which is a the bottom of the left hand menu bar. Just click to add the newsletter and the BLOG, and the content will automatically appear on your Yahoo! home page shortly after it is published. At your Yahoo! home page, you can click on the Change Layout button, and move it wherever you want on the page.

Internet Explorer and Outlook are a little trickier. For Outlook 2007- I don't know if it works on previous versions- start at the OTC Journal Home Page at the bottom of the left hand menu bar where you find the RSS Feeds. Right click on OTCJ Newsletter RSS Feed 2.0, and copy link. 

Then go to Outlook- Go through the following tabs- Tools, Account Settings, RSS Feeds. Then Click on New, and paste the link into the window. Then click OK, OK, and close. Repeat procedure for the OTCJ Blog RSS 2.0. From there forward, both the editions and the BLOG will automatically show up in your RSS feeds folder.

Internet Explorer 7.0 has another trick. Here, you have to go to the little star in the upper left hand corner with the green plus sign, click Add to Favorites, and copy and paste in the same links you used for Outlook. You can also go to the RSS button on the right hand side of the page, but you need to go to a BLOG to use the button.

Microsoft has an instruction page you can find by clicking here which gives a bit more information and probably better instruction. 

If you want to insure delivery and bypass emails, those are several choices. Worth a few minutes to figure it out. It works really well with Outlook 2007 and a Yahoo! home page. Perhaps your email software allows RSS feeds as well. 
 

  Apple Could Be Turning From Rotten To Ripe For the Plucking  

Coulda, Shoulda, Woulda. No courage. On January 15 I published a very brief BLOG post Q1 earnings for the digital entertainment giant. Simply stated, AAPL delivered stellar earnings, and the stock was getting killed. I liquidated all my positions at $172, and decided to stay firmly planted on the sidelines. 

The market liked the numbers, but hated the slightly lower than expected sales of iPods- investors assumed their revolutionary music player has finally peaked and headed down the back of the mountain. I would suggest the iPod might have a few more years to climb. The product is being adopted by an "older generation", fueled by iPod docking stations in cars and on home digital entertainment systems.

This darling of the last Bull Market run has been taken out to the woodshed an absolutely beaten to death by the momentum players and short sellers. 

Reference my January 23rd BLOG on AAPL- I suggested AAPL had the chance of finding its way all the way back to $108.50, giving up nearly half its value from the $200 high. Momentum can work both ways- the stock has momentum to the downside. Woulda, shoulda, coulda bought a put or gone short the day I decided to liquidate. Darn- $10k probably would have turned into about $50k thanks to the Bear claws.

As the stock approaches my absolutely ideal level of $108.50, it's worth taking another look at the chart. Here's a weekly chart going back to the $52 level early in the summer of 2007.

As you can see, on this chart the 61.8% Fibonacci retracement level is a touch higher than $108.50- it's at the $109.83 level. In either case- both numbers are just under $110.

Shares of AAPL have now dropped below the $120 level, and could be starting some sort of bottoming process. I can't say for sure how low it will go. Perhaps it made its lows this past week. I'm going to be watching carefully for a drop below $110. It will probably be short lived. It would represent a very promising and irresistible level to own AAPL. 

On Friday, and hour before the market closed, stocks rebounded beautifully after another 1% drop across all the indexes in four holiday shortened trading days. Rumors of bond insurer bail outs sent the market up in the 11th hour. With all the S**T around, there's got to be a pony somewhere. Next week could be much improved.

Last weekend's suggestion to buy QQQQ calls was a loser. I sold mine for a $1,000 loss, then bought back on Thursday. I fininshed slightly in the money on Friday.

This weekend I am going to suggest a trade that has worked for me once this year already. I believe- #1- stocks are ready for a little bit more of a sustained rebound- I thought it might come last week, but no such luck. #2- Time Warner looks like it wants to participate.

If TWX opens quietly or down a little on Monday, I plan to jump into the March 16 Calls. If I can get 1 to 1.5 points next week, I will happily jump out and take my profit. A 1/2 point drop in the stock will result in closing out the position and taking the loss.

The stock probably wants to pierce the 3x3 moving average you see in blue and head higher. 

On Monday I will set up a new BLOG for these short term trades, which can be a lot of fun and a good way to make some trading profits in this brutal market environment.

Use the RSS Feeds to bypass emails if you want to receive the OTC Journal reliably.
 

  Subscribe  

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Subscribe Here

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

  Refer A Friend  

If you find the OTC Journal informative and profitable, please forward our newsletter alert service to like-minded friends and associates who share similar market interests.


  Ensure Newsletter Delivery  

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition. 

Disclaimer
The OTC Journal Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features. Likewise, this newsletter is owned by MarketByte, LLC. To the degrees enumerated herein, this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address: http://www.otcjournal.com/disclosure/compensation/section/profile/ for our full profiles and http://www.otcjournal.com/disclosure/compensation/section/alert/ for Trading Alerts.

(Insert specific company compensation here)

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte, LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

The Trustee of the MarketByte, LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund. Longview ocassoinally refers companies to MarketByte, LLC for possible coverage by one of the MarketByte, LLC publications, which publications include the OTC Journal Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte, LLC. The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte, LLC client companies. 

The profiles, critiques, and other editorial content of the OTC Journal may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.COM.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID: Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.


You can unsubscribe from this list at any time by Clicking Here. If you are having difficulty removing yourself or wish to change your address please go to http://www.otcjournal.com/opt/?.

 

Disclaimer

The OTC Journal Newsletter is an electronic publication committed to providing our readers with useful information on publicly traded companies. The Newsletter contracts with publicly traded companies and receives compensation from them or third parties as payment for publishing information and opinions about the company and the trading market for their securities. Principals of the Newsletter may also purchase or sell securities of the companies in the open market from time to time. The positions, if any, that the Newsletter or its principals presently maintain in the securities of the companies are disclosed here (click here) and should be considered in making an investment decision regarding these companies securities. The Newsletter and its principals reserve the right to acquire additional shares or liquidate some or all of the positions they may hold in the issuer’s securities at any time in the future without further notice. These publications should not be considered to be independent publications concerning the company.

All statements and opinions expressed herein are those of the editors and are subject to change without notice. The Newsletter maintains editorial control over its publications and the companies profiled therein do not have any editorial rights concerning the information published about them. While we believe all sources of information provided by us and contained in our publication to be accurate and reliable, we cannot and do not guarantee the accuracy of information we received from third parties.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.finra.org. We also recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.

The information found in this profile is protected by the copyright laws of the United States and may not be copied, or reproduced in any way without the express written consent of the editors of otcjournal.com.

UNSUBSCRIBE

You can unsubscribe from this list at any time by Clicking Here. If you are having difficulty removing yourself or wish to change your address please go to http://www.otcjournal.com/opt/.